Market Overview

From Biogen Call: Eloctate Could Be Facing Potential Approval Delay

Related BIIB
Deutsche Bank Analyst Talks Up Biogen On CNBC; Stock Responds Slightly
Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector
Don't Panic Over Recent Tech Turmoil (Fox Business)

Posted-In: News FDA


Most Popular

Related Articles (BIIB)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free